Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Editas Medicine (EDIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,054,264
  • Shares Outstanding, K 42,120
  • Annual Sales, $ 6,050 K
  • Annual Income, $ -97,180 K
  • 36-Month Beta 4.84
  • Price/Sales 169.37
  • Price/Cash Flow 0.00
  • Price/Book 5.76

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.29 +23.02%
on 11/08/17
25.90 -3.63%
on 11/16/17
+1.76 (+7.59%)
since 10/17/17
3-Month
17.35 +43.86%
on 08/21/17
26.75 -6.69%
on 10/04/17
+6.16 (+32.77%)
since 08/17/17
52-Week
13.12 +90.24%
on 05/31/17
29.20 -14.52%
on 03/14/17
+9.30 (+59.39%)
since 11/17/16

Most Recent Stories

More News
Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed(TM) Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

Torque, an immuno-oncology company developing Deep Primed(TM) cell therapies that direct and evoke immune responses in the tumor microenvironment, today announced the launch of its technology platform...

SYRS : 12.33 (+1.82%)
MCRB : 9.57 (+2.68%)
RYTM : 24.61 (+1.99%)
EDIT : 24.93 (-0.40%)
MACK : 11.73 (+0.69%)
mHealth and Telemedicine Innovation Vastly Improving Healthcare Services for Patients

PALM BEACH, Florida, November 9, 2017 /PRNewswire/ --

SGMO : 14.65 (+0.34%)
RHT.VN : 0.780 (-2.50%)
RQHTF : 0.6218 (+1.24%)
ARRY : 11.65 (+4.20%)
EDIT : 24.93 (-0.40%)
THC : 13.29 (-2.28%)
mHealth and Telemedicine Innovation Vastly Improving Healthcare Services for Patients

Telemedicine and mHealth services, apps and platforms are increasingly gaining a foothold over traditional healthcare as a result of the rising use of telecommunication to deliver innovative healthcare...

SGMO : 14.65 (+0.34%)
RHT.VN : 0.780 (-2.50%)
RQHTF : 0.6218 (+1.24%)
ARRY : 11.65 (+4.20%)
EDIT : 24.93 (-0.40%)
THC : 13.29 (-2.28%)
Editas Medicine Announces Third Quarter 2017 Results and Update

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today reported financial results for the third quarter ended September 30, 2017, and provided an update on recent achievements and...

EDIT : 24.93 (-0.40%)
What's in the Cards for Adverum (ADVM) This Earnings Season?

Adverum Biotechnologies (ADVM) will report its third-quarter results later this month. Investors focus is expected to be on pipeline updates.

ADVM : 3.13 (-0.79%)
EDIT : 24.93 (-0.40%)
ACAD : 27.55 (-0.33%)
REGN : 392.22 (-0.63%)
Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, November 7, 2017, at 5:00 p.m. ET to discuss a corporate...

EDIT : 24.93 (-0.40%)
Telemedicine Innovation Changing the Landscape of Traditional Healthcare

PALM BEACH, Florida, November 2, 2017 /PRNewswire/ --

KND : 7.60 (-1.30%)
SGMO : 14.65 (+0.34%)
RHT.VN : 0.780 (-2.50%)
RQHTF : 0.6218 (+1.24%)
ACHN : 3.47 (-2.53%)
EDIT : 24.93 (-0.40%)
Telemedicine Innovation Changing the Landscape of Traditional Healthcare

Telemedicine is increasingly gaining popularity over traditional healthcare owing to the rising use of telecommunication to deliver various healthcare services to patients. The telemedicine market in the...

SGMO : 14.65 (+0.34%)
KND : 7.60 (-1.30%)
RHT.VN : 0.780 (-2.50%)
RQHTF : 0.6218 (+1.24%)
ACHN : 3.47 (-2.53%)
EDIT : 24.93 (-0.40%)
Editas Medicine Demonstrates Dose-Dependent, In Vivo Editing with EDIT-101 in CEP290 Transgenic Mice

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study in transgenic mice demonstrating dose-dependent, in vivo editing using EDIT-101,...

EDIT : 24.93 (-0.40%)
Editas Medicine to Participate in Investor Conferences in October

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in New York in October. Details are as follows:...

EDIT : 24.93 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 26.66
1st Resistance Point 25.85
Last Price 24.93
1st Support Level 24.27
2nd Support Level 23.50

See More

52-Week High 29.20
Last Price 24.93
Fibonacci 61.8% 23.06
Fibonacci 50% 21.16
Fibonacci 38.2% 19.26
52-Week Low 13.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart